Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

William Grande

Vascular & Interventional Radiology Englewood, CO Medical Doctor

NPI 1679785653 CMS profile 257346

10800 E Geddes Ave Ste 300, Englewood, CO 80112

Open in the dashboard

General payments

$6,779

139 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, William Grande of Englewood, CO is reported in the CMS Open Payments database as having received $6,779 across 139 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 70th percentile of Vascular & Interventional Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,065 19
2024 General $925 26
2023 General $847 17
2022 General $1,226 23
2021 General $719 19
2020 General $797 13
2019 General $1,200 22

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • William Grande
  • Vascular & Interventional Radiology median
  • Middle half of Vascular & Interventional Radiology
  • National median

In program year 2025, general payments to William Grande were reported at $1,065. Among 3,393 Vascular & Interventional Radiology profiles paid that year, the median was $534 and the middle half received between $166 and $2,075.

Show as a table
Year William Grande Vascular & Interventional Radiology median Middle half National median
2019 $1,200 $422 $125–$1,555 $163
2020 $797 $200 $68–$652 $114
2021 $719 $280 $99–$866 $132
2022 $1,226 $433 $137–$1,497 $149
2023 $847 $506 $152–$2,019 $160
2024 $925 $556 $175–$1,930 $164
2025 $1,065 $534 $166–$2,075 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Inari Medical, Inc. $1,676 13 payments
  2. Boston Scientific Corporation $1,129 23 payments
  3. W. L. Gore & Associates, Inc. $669 20 payments
  4. Tactile Systems Technology Inc $434 7 payments
  5. Stryker Corporation $424 5 payments
  6. AngioDynamics, Inc. $297 12 payments
  7. Sirtex Medical Inc $283 5 payments
  8. Cook Medical LLC $247 4 payments
  9. Penumbra, Inc. $233 1 payment
  10. Abbott Laboratories $218 5 payments
  11. Other $1,170 44 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $6,779 139 payments
Products named General payments · program years 2019–2025
  1. FLOWTRIEVER CATHETER, S $1,639 12 payments
  2. CT THROMBECTOMY SYSTEM KIT $1,287 10 payments
  3. SIR-Spheres Microspheres $283 5 payments
  4. Penumbra System $233 1 payment
  5. ENTRE $217 3 payments
  6. ACTITOUCH $217 3 payments
  7. FLEXITOUCH $217 3 payments
  8. Flexitouch Plus $217 4 payments
  9. ClotTriever $213 2 payments
  10. FlowTriever $213 2 payments
  11. Other $4,366 113 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 2 drugs

Part D claims

60

Median for Interventional Radiology: 38

Drug cost

$13,359

Median for Interventional Radiology: $333

Branded share of claims

100%

Median for Interventional Radiology: 53%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 21 $13,178
Clopidogrel Clopidogrel Bisulfate Brand 39 $180

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 554 Part D prescribers listed as Interventional Radiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 171 billing codes

Paid by Medicare

$169,337

Of which drugs: $353

Medicare patients

944

Average age 75

Services billed

4,111

489 women, 455 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 57%
Ischemic heart disease 39%
Chronic kidney disease 35%
Diabetes 31%
Heart failure 26%
COPD 26%
Atrial fibrillation 25%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml Q9967 Office 27 2,497 $260
Injection, fentanyl citrate, 0.1 mg J3010 Office 14 27 $20
Injection, midazolam hydrochloride, per 1 mg J2250 Office 16 51 $6

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

139 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular & Interventional Radiology in Colorado

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record